HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation analysis of DARPP-32 as a candidate gene for schizophrenia.

Abstract
Dopamine- and cAMP-regulated phosphoprotein of relative molecular mass 32kDa (DARPP-32) plays a pivotal role in the signal transduction of several neurotransmitters and neuromodulators that are implicated in the pathophysiology of a variety of neuropsychiatric disorders. A postmortem study reported a significantly reduced DARPP-32 expression in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, suggesting possible involvement of DARPP-32 in the pathophysiology of schizophrenia. Hence, DARPP-32 was considered as a candidate gene for schizophrenia in this study. We first systemically searched for mutations in the DARPP-32 gene in 50 Han Chinese patients with schizophrenia from Taiwan. Five molecular variants were identified, including a C-to-G substitution (g.-2036C>G) in the putative core promoter that obliterated a predictive AP-2 transcription factor binding site, a G deletion in the untranslated exon 2 (g.1238delG), a G-to-A and an A-to-G substitutions in intron 2 (IVS2+31G>A) and intron 6 (IVS6+32A>G), respectively, and a three-base pair deletion of AGA in exon 6 that resulted in deletion of a glutamate at codon 135 (E135del). Further SNP- and haplotype-based association study in 249 patients and 273 control subjects, however, did not detect association of these markers with schizophrenia. Hence, our results suggest that the reduced DARPP-32 protein in patients with schizophrenia is unlikely caused by mutations in the DARPP-32 gene itself and the DARPP-32 gene is also unlikely a major susceptibility gene for schizophrenia. Nevertheless, the identification of these molecular variants should help the study of gene regulation and structure-function relationship of DARPP-32, and the association study of DARPP-32 gene with other neuropsychiatric disorders.
AuthorsChen-Hao Li, Hsiao-Mei Liao, Tsai-Wei Hung, Chia-Hsiang Chen
JournalSchizophrenia research (Schizophr Res) Vol. 87 Issue 1-3 Pg. 1-5 (Oct 2006) ISSN: 0920-9964 [Print] Netherlands
PMID16750903 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Cyclic AMP
Topics
  • Alleles
  • Binding Sites
  • Cyclic AMP (genetics, metabolism)
  • DNA Fragmentation
  • DNA Mutational Analysis (methods)
  • DNA Primers (genetics)
  • Dopamine and cAMP-Regulated Phosphoprotein 32 (genetics)
  • Exons (genetics)
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Inteins (genetics)
  • Male
  • Middle Aged
  • Point Mutation (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide (genetics)
  • Schizophrenia (genetics, metabolism, physiopathology)
  • Transcriptional Activation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: